|
This report is being submitted to relay additional information and device evaluation.The following sections are being reported: b4: date of this report was updated.G3: date received by manufacturer was updated.G6: type of report was updated.H2: type of follow up was updated.H3: device evaluated by manufacturer was updated.H6: investigation type codes were added: 3331, 4109 and 4111.H6: investigation findings code was added: 213.H6: investigation conclusions codes were added: 4310.H10: narrative/data was updated.Zimvie receives (1) 3i t3 tapered implant, (bopt6585) for investigation.Visual/physical evaluation of the as returned product identified signs of use but no apparent signs of malfunction.Dhr review was completed for the subject lot number 2022040755.No deviations or non-conformance's, which could have caused or contributed to the reported event, were noted as part of the dhr.Complaint history review was performed for the reported lot number 2022040755 for similar events and no other complaint was identified.Based on the investigation and risk management file review, the most likely root causes determined from the investigation were patient factors and improper techniques.Therefore, based on the available information, device malfunction did not occur.Additionally, the reported event could not be verified as the exact details of event were unknown/unverifiable.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the product was nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.
|